# A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

> **NCT03326518** · PHASE2 · TERMINATED · sponsor: **Lument AB** · enrollment: 45 (actual)

## Conditions studied

- Subjects Referred to CT-examination of the Abdomen

## Interventions

- **DIAGNOSTIC_TEST:** Lumentin® 44
- **DIAGNOSTIC_TEST:** Diluted Omnipaque®
- **DIAGNOSTIC_TEST:** Movprep®

## Key facts

- **NCT ID:** NCT03326518
- **Lead sponsor:** Lument AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-28
- **Primary completion:** 2018-09-30
- **Final completion:** 2019-02-15
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** Primary objective reached
- **Last updated:** 2020-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03326518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03326518, "A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03326518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*